RT @Azeem_Majeed: @Madeinavalon This article concluded that "UK recommendations to provide shorter prescriptions are not substantiated by t…
@Madeinavalon This article concluded that "UK recommendations to provide shorter prescriptions are not substantiated by the current evidence base". https://t.co/tLGE8QQq6a
@Azeem_Majeed @gregjirving https://t.co/q0tEfwTsff @BJGPjournal systematic review ‘longer prescriptions are associated with better adherence’ - certainly no 28d standard- likely most should be 2-3mths or eg cocp for 6-12mths
RT @pash22: Insufficient evid relating to overall impact of differing prescription lengths on clin and health service outcomes. UK recommen…
Insufficient evid relating to overall impact of differing prescription lengths on clin and health service outcomes. UK recommendations to provide shorter prescriptions are not substantiated by the current evidence base. https://t.co/jkoJjLv60d via @celine_
@domcavlan As @TomPMarshall mentions, 28 day repeats are detrimental to patient adherence with long term therapies. These patients are by definition 4 times as likely to run out (whether through absentmindedness or systems failures) as those on 84 day repe
RT @TomPMarshall: @domcavlan OK - got it. I remembered there was a systematic review https://t.co/wHskGTTijU
@domcavlan OK - got it. I remembered there was a systematic review https://t.co/wHskGTTijU
@UnhealthyEcon @WLancsGP CCGs and NHS England are concerned about drug wastage - even though a systematic review on this question did not find this was a problem with longer prescription lengths. https://t.co/tLGE8QQq6a
@SDawlatly @MindthegapMum That is often given as a reason Samir but a systematic review on this question did not find much benefit from shorter prescription lengths. https://t.co/tLGE8QQq6a
RT @BoSoBoSoSan: 長期処方と短期処方の比較。長期処方のほうが服薬アドヒアランスはいい可能性があり、短期処方を推奨する理由は現時点のエビデンスでは説明しにくいとの主張。 Impact of issuing longer- versus shorter-durat…
RT @BoSoBoSoSan: 長期処方と短期処方の比較。長期処方のほうが服薬アドヒアランスはいい可能性があり、短期処方を推奨する理由は現時点のエビデンスでは説明しにくいとの主張。 Impact of issuing longer- versus shorter-durat…
長期処方と短期処方の比較。長期処方のほうが服薬アドヒアランスはいい可能性があり、短期処方を推奨する理由は現時点のエビデンスでは説明しにくいとの主張。 Impact of issuing longer- versus shorter-duration prescriptions: a systematic review https://t.co/mXHQsW2ay4
RT @BJGPjournal: BJGP in the News: Impact of issuing longer- versus shorter- duration prescriptions. Read the original at: https://t.co/s1D…
RT @BJGPjournal: BJGP in the News: Impact of issuing longer- versus shorter- duration prescriptions. Read the original at: https://t.co/s1D…
BJGP in the News: Impact of issuing longer- versus shorter- duration prescriptions. Read the original at: https://t.co/s1DoU5rIlt The Conversation: https://t.co/jWVd2SM7Zp (13 April 2018) https://t.co/XxsN5fG9dc
Hmmm. *May* also increase medicines waste. I think my point is that this is a very grey area - definitely one where more research is needed (yes, I know - that's what academics always say) https://t.co/cvoFAQvJr2
Have long believed this for some patients https://t.co/ZokTiiIxWT
RT @BJGPjournal: Longer prescriptions may improve medication adherence, and also reduce GP workload, contrary to UK recommendations https:/…
RT @BJGPjournal: Longer prescriptions may improve medication adherence, and also reduce GP workload, contrary to UK recommendations https:/…
Longer prescriptions may improve medication adherence, and also reduce GP workload, contrary to UK recommendations https://t.co/BmGkzUTREq https://t.co/lwmkUTmC9E
RT @celine_miani: Patients w/ stable #chronic conditions would rather not pick up a #prescription every single month. And they don't necess…
RT @celine_miani: Patients w/ stable #chronic conditions would rather not pick up a #prescription every single month. And they don't necess…
RT @celine_miani: Patients w/ stable #chronic conditions would rather not pick up a #prescription every single month. And they don't necess…
Patients w/ stable #chronic conditions would rather not pick up a #prescription every single month. And they don't necessarily have to: 3 month prescriptions can be safe and cost-effective https://t.co/tYA7wszgxS @BJGP @DrRupertPayne @capcbristol @RANDEuro
RT @patientconnect1: Prescriptions covering just 28 days are not based on sound evidence and could be increased for stable conditions such…
RT @capcbristol: 'Academics urge rethink on 28-day #prescriptions for people with long-term conditions': research behind the headline: @BJG…
The study included (1) a systematic review https://t.co/tYA7wszgxS in @BJGP
RT @RPS_Wales: RT @AndrewEvansCPhO: Important research into lack of evidence to support shorter prescription intervals - time to consider c…
RT @RPS_Wales: RT @AndrewEvansCPhO: Important research into lack of evidence to support shorter prescription intervals - time to consider c…
RT @AndrewEvansCPhO: Important research into lack of evidence to support shorter prescription intervals - time to consider change in policy to benefit GPs, community pharmacies and patients? https://t.co/nuFt0fAeN2
@ChrisStockport1 @Wilko72B Reduce volume ?All to 3 mthly batches, plus One or two reg items to 6-12 mths. Just a thought! Free up pharmacists! https://t.co/qaqELVDuBy
RT @capcbristol: 'Academics urge rethink on 28-day #prescriptions for people with long-term conditions': research behind the headline: @BJG…
RT @capcbristol: 'Academics urge rethink on 28-day #prescriptions for people with long-term conditions': research behind the headline: @BJG…
RT @capcbristol: 'Academics urge rethink on 28-day #prescriptions for people with long-term conditions': research behind the headline: @BJG…
RT @capcbristol: 'Academics urge rethink on 28-day #prescriptions for people with long-term conditions': research behind the headline: @BJG…
RT @capcbristol: 'Academics urge rethink on 28-day #prescriptions for people with long-term conditions': research behind the headline: @BJG…
@AndrewEvansCPhO Careful consideration needs to be given to this evidence, how it could affect practice, and the knock on implication for community pharmacy workload, workforce and opportunities for reinvestment of these resources while maintaining sector
Impact of issuing longer- versus shorter- duration prescriptions: a systematic review https://t.co/uWZ0ZGIm6E
RT @FutureGenPrac: Longer (2-4 months) or shorter (28day) prescriptions for patients in Primary Care? #systematicreview https://t.co/7Q…
RT @AndrewEvansCPhO: Important research into lack of evidence to support shorter prescription intervals - time to consider change in policy…
RT @capcbristol: 'Academics urge rethink on 28-day #prescriptions for people with long-term conditions': research behind the headline: @BJG…
'Academics urge rethink on 28-day #prescriptions for people with long-term conditions': research behind the headline: @BJGPjournal - https://t.co/Nz78SyGgrj @ApplHealthEcon - https://t.co/wZ0MUEttqb @BMJ_Open - https://t.co/2six2eNCDw @OfficialNIHR - https
RT @FutureGenPrac: Longer (2-4 months) or shorter (28day) prescriptions for patients in Primary Care? #systematicreview https://t.co/7Q…
RT @AndrewEvansCPhO: Important research into lack of evidence to support shorter prescription intervals - time to consider change in policy…
RT @LSHTMEvaluation: Systematic review: 9 studies found longer prescription length associated with increased medication #adherence and 6 st…
RT @BJGPjournal: Out today, online first: Impact of issuing longer- versus shorter- duration prescriptions https://t.co/Z8FpVkzjQb https://…
RT @AndrewEvansCPhO: Important research into lack of evidence to support shorter prescription intervals - time to consider change in policy…
Important research into lack of evidence to support shorter prescription intervals - time to consider change in policy to benefit GPs, community pharmacies and patients? https://t.co/l6XCilSI5O
Impact of issuing longer- versus shorter- duration prescriptions: a systematic review https://t.co/68pNLckjD5
RT @FutureGenPrac: Longer (2-4 months) or shorter (28day) prescriptions for patients in Primary Care? #systematicreview https://t.co/7Q…
Longer (2-4 months) or shorter (28day) prescriptions for patients in Primary Care? #systematicreview https://t.co/7Qx38lkY1e https://t.co/3ghcvdDFkk
RT @capcbristol: More coverage of research by @DrRupertPayne & @RANDEurope urging rethink of 28-day prescriptions for people with long-term…
RT @BJGPjournal: Impact of issuing longer- versus shorter- duration prescriptions https://t.co/Z8FpVkzjQb https://t.co/tMn47Eo8rh
RT @capcbristol: More coverage of research by @DrRupertPayne & @RANDEurope urging rethink of 28-day prescriptions for people with long-term…
RT @capcbristol: More coverage of research by @DrRupertPayne & @RANDEurope urging rethink of 28-day prescriptions for people with long-term…
More coverage of research by @DrRupertPayne & @RANDEurope urging rethink of 28-day prescriptions for people with long-term conditions. See @BJGPjournal & @ApplHealthEcon papers published today: https://t.co/dvJU0LveyS & https://t.co/17nmc9yqU7
As a patient with LTC So agree @DrRupertPayne @BJGPjournal https://t.co/1FXJDdIqwV
So, my GPs may have been on to something when they changed to 56 day scripts, although individualisation is still needed. https://t.co/RXlzAYrqGu
RT @BJGPjournal: Out today, online first: Impact of issuing longer- versus shorter- duration prescriptions https://t.co/Z8FpVkzjQb https://…
RT @BJGPjournal: Impact of issuing longer- versus shorter- duration prescriptions https://t.co/Z8FpVkzjQb https://t.co/tMn47Eo8rh
RT @BJGPjournal: Impact of issuing longer- versus shorter- duration prescriptions https://t.co/Z8FpVkzjQb https://t.co/tMn47Eo8rh
Systematic review: 9 studies found longer prescription length associated with increased medication #adherence and 6 studies suggested that longer prescriptions may increase medication waste https://t.co/VZEJQqbQay
Out today, online first: Impact of issuing longer- versus shorter- duration prescriptions https://t.co/Z8FpVkzjQb https://t.co/bdTpr1eh48
Impact of issuing longer- versus shorter- duration prescriptions https://t.co/Z8FpVkzjQb https://t.co/tMn47Eo8rh
RT @RANDEurope: New paper in @BJGPjournal outlines the challenges with current guidance on 28-day repeat prescriptions. Particularly for ch…
New paper in @BJGPjournal outlines the challenges with current guidance on 28-day repeat prescriptions. Particularly for chronic conditions where patients & the #NHS could benefit from longer prescriptions https://t.co/vtR3Anj7IT